HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Complementation Group E Xeroderma Pigmentosum

mutation in DDB2
Also Known As:
Xeroderma Pigmentosum, Complementation Group E; XP, Group E; XP5; XPE; Xeroderma Pigmentosum V
Networked: 76 relevant articles (3 outcomes, 3 trials/studies)

Relationship Network

Disease Context: Research Results

Related Diseases

1. Hypoxia (Hypoxemia)
2. Xeroderma Pigmentosum (Kaposi's Disease)
3. Complementation Group E Xeroderma Pigmentosum
4. Neoplasms (Cancer)
5. Stomach Neoplasms (Stomach Cancer)

Experts

1. Bagchi, Srilata: 4 articles (01/2020 - 06/2009)
2. Raychaudhuri, Pradip: 4 articles (01/2020 - 06/2009)
3. Sugasawa, Kaoru: 3 articles (09/2015 - 09/2006)
4. Mori, Toshio: 3 articles (12/2005 - 01/2002)
5. Balupillai, Agilan: 2 articles (01/2020 - 01/2018)
6. Bommi, Prashant V: 2 articles (01/2020 - 06/2013)
7. Muratoglu, Orhun K: 2 articles (01/2019 - 01/2018)
8. Oral, Ebru: 2 articles (01/2019 - 01/2018)
9. Xu, Jia-Zhuang: 2 articles (01/2019 - 01/2018)
10. Kopanja, Dragana: 2 articles (06/2013 - 06/2009)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Complementation Group E Xeroderma Pigmentosum:
1. ultra-high molecular weight polyethylene (UHMWPE)IBA
2. Polyethylene (Polythene)IBA
3. Reactive Oxygen Species (Oxygen Radicals)IBA
4. Vitamin EFDA LinkGeneric
5. SqualeneIBA
6. SaltsIBA
7. MetalsIBA
8. LithiumIBA
9. ElectrolytesIBA
10. lithium bis(fluorosulfonyl)imideIBA

Therapies and Procedures

1. Electrodes (Electrode)
2. Radiotherapy
3. Knee Replacement Arthroplasty (Total Knee Replacement)
4. Inlays (Inlay)